New Covenant Trust Company’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
4,049
+234
+6% +$54.5K 0.78% 27
2026
Q1
$933K Buy
3,815
+677
+22% +$158K 0.83% 25
2025
Q4
$651K Buy
3,138
+23
+0.7% +$4.55K 0.59% 29
2025
Q3
$578K Sell
3,115
-31
-1% -$5.31K 0.54% 34
2025
Q2
$479K Sell
3,146
-183
-5% -$28.1K 0.43% 36
2025
Q1
$545K Sell
3,329
-245
-7% -$38.3K 0.58% 32
2024
Q4
$512K Sell
3,574
-281
-7% -$43.5K 0.51% 35
2024
Q3
$622K Sell
3,855
-23
-0.6% -$3.67K 0.6% 31
2024
Q2
$600K Sell
3,878
-208
-5% -$30.9K 0.69% 26
2024
Q1
$646K Buy
+4,086
New +$650K 0.65% 25

Other funds holding JNJ

New Covenant Trust Company's JNJ Position: Q2 2026 in Review

New Covenant Trust Company increased its Johnson & Johnson (JNJ) stake by 6.1% in Q2 2026, buying an estimated $54.5K and bringing the position to 4,049 shares worth $1.03M. The position accounts for 0.78% of the portfolio, ranked #27.

New Covenant Trust Company first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • New Covenant Trust Company held 4,049 shares of Johnson & Johnson worth $1.03M as of Q2 2026.
  • New Covenant Trust Company bought 234 Johnson & Johnson shares in Q2 2026, an estimated $54.5K.
  • Johnson & Johnson made up 0.78% of New Covenant Trust Company's portfolio in Q2 2026, its #27 holding.
  • New Covenant Trust Company first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on New Covenant Trust Company's 13F filing for Q2 2026, filed 14 Jul 2026.